Labs / ADME, DMPK & toxicology
Enlaza Therapeutics
La Jolla, CA, United States · enlazatx.com
On your own
Free. Their own form.
Through Midgard
Midgard sends your request to the lab and keeps the order's messages, papers and payments in one place. Free to ask. 1% platform fee if you keep the order on Midgard.
Enlaza Therapeutics develops covalent protein therapeutics using its War-Lock platform. The company is based in La Jolla, California and is focused on cancer and other serious diseases.
Their website has a general contact form; we send your quote request through it.
What they offer
Covalent biologic discovery and development
Develops first-in-class covalent protein therapeutics using the War-Lock platform to create highly selective biologic drugs.
Protein engineering with unnatural amino acids
Incorporates proprietary unnatural amino acids into protein drugs to enable covalent target binding while preserving drug-like properties.
Antibody-drug conjugate enablement
Modifies protein drugs with payloads to create ADCs with specific target tissue delivery.
What they work on
- Modalities
- Small molecule, Antibody, ADC, Cell therapy
- Species and models
- E. coli
- Therapeutic areas
- cancer, serious diseases
- Minimums and prices
- $61 million seed financing
- Sites
- La Jolla, United States
- Address
- 11099 North Torrey Pines Road, Ste 280 La Jolla, California, 92037
- Founded
- 2022
Similar labs. Evotec, ProtaGene, Vaxcyte, Hope Medicine (HopeMed)
Found in a contract services directory. Listing built from enlazatx.com. Work here? Claim this listing.